Scientific Advisory Board Cutaneous T-Cell Lymphoma
Our scientific advisory board for Cutaneous T-Cell Lymphoma includes some of the most senior and renowned experts in the diagnosis and treatment of CTCL. Collectively they have been involved in at least 45 clinical trials.
Youn Kim, MD
Professor for Cutaneous Lymphoma at Stanford University, Director of the Multi-disciplinary Cutaneous Lymphoma Program and Medical Director of the photopheresis Unit at Stanford Medical Center, and Co-Director of the Lymphoma Research Program at the Stanford Cancer Institute
Gary Wood, MD
Chair and Professor of Dermatology at the University of Wisconsin and President of the International Society for Cutaneous Lymphomas
Madeleine Duvic, MD
Professor of Internal Medicine and Dermatology, and Deputy Chairman of the Department of Dermatology at The University of Texas, MD Anderson Cancer Center, and Founding Member of the US Cutaneous Lymphoma Consortium
Resources:
Phase 3 top-line results
Phase 3 extended results
Phase 3 final results
Phase 2 paper: Rook, A.H., Wood, G.S., Duvic, M., Vonderheid, E.C., Tobia, A., Cabana, B. A phase II placebo-controlled study of photodynamic therapy with topical hypericin and visible light irradiation in the treatment of cutaneous T-cell lymphoma and psoriasis. 2010.